Amneal Pharmaceuticals, Inc. - 8-K Filing

Amneal Pharmaceuticals stockholders approved the acquisition of Kashiv BioSciences on July 31, 2026. (Items: 5.07 Submission of Matters to a Vote of Security Holders)

SEC EDGAR ·

Tickers: $AMRX

Read the full article at SEC EDGAR

More Regulatory news